Positional cloning moves from perditional to traditional

The technique of positional cloning has become a familiar component of modern human genetics research. After a halting start in the mid–1980s, the number of disease genes succumbing to cloning efforts based solely on pinpointing their position in the genome is growing exponentially. More than 40 genes have been identified so far. But the positional candidate approach, which combines knowledge of map position with the increasingly dense human transcript map, greatly expedites the search process and will soon become the predominant method of disease gene discovery. The challenge ahead is to apply such methods to identifying genes involved in complex polygenic disorders.

[1]  A. Ballabio.  The rise and fall of positional cloning? , 1993, Nature Genetics.

[2]  D. Church,et al.  Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia , 1994, Cell.

[3]  J. Todd,et al.  Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus , 1995, Nature Genetics.

[4]  S. P. Fodor,et al.  Light-generated oligonucleotide arrays for rapid DNA sequence analysis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Housman,et al.  A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4. , 1991, Genomics.

[6]  Ada Hamosh,et al.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene , 1991, Nature.

[7]  J. Todd,et al.  A genome-wide search for human type 1 diabetes susceptibility genes , 1994, Nature.

[8]  B. Ponder,et al.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A , 1993, Nature.

[9]  J. Witte,et al.  Genetic dissection of complex traits. , 1994, Nature genetics.

[10]  Eric S. Lander,et al.  The diastrophic dysplasia gene encodes a novel sulfate transporter: Positional cloning by fine-structure linkage disequilibrium mapping , 1994, Cell.

[11]  B. Ponder,et al.  Mutations of the RET proto-oncogene in Hirschsprung's disease , 1994, Nature.

[12]  C. Maslen,et al.  Localization of the fibrillin (FBN) gene to chromosome 15, band q21.1. , 1991, Genomics.

[13]  R. Fleischmann,et al.  Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer , 1994, Nature.

[14]  Ruddle Fh.  The William Allan Memorial Award address: Reverse genetics and beyond. , 1984 .

[15]  Robin J. Leach,et al.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.

[16]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[17]  F. Collins,et al.  Positional cloning: Let's not call it reverse anymore , 1992, Nature Genetics.

[18]  A. Monaco,et al.  Cloning the gene for an inherited human disorder—chronic granulomatous disease—on the basis of its chromosomal location , 1986, Nature.

[19]  H. Lehrach,et al.  Trinucleotide repeat expansions and human genetic disease. , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[20]  L. Peltonen,et al.  Location on chromosome 15 of the gene defect causing Marfan syndrome. , 1990, The New England journal of medicine.

[21]  T. Lairmore,et al.  Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A. , 1991, Genomics.